Taiai Peptide Group Attends the “2023 Forum on Innovative Development of Bioactive Peptides and Special Medical Food Technology”

To further address the key issues of technological innovation in the bioactive peptides and specialty food industries, carry out technological cooperation, accelerate the transfer and transformation of scientific and technological achievements, enhance the overall competitiveness of the industry, and provide talent support for sustained innovation in the industry, On April 20-22, 2023, the “2023 Bioactive Peptides and Special Medical Food Technology Innovation and Development Forum” and the “First Annual Meeting of the Special Medical Food and Bioactive Peptides Working Committee and the Establishment Conference of the Expert Committee” were successfully held in Guangzhou. Taiai Peptide Group, as a vice chairman unit and vice chairman unit, was invited to attend this forum. The conference invited leaders from relevant national departments, industry renowned experts and scholars, and outstanding enterprise representatives to give speeches and engage in thematic exchanges.

On the morning of the 20th, the “2023 Bioactive Peptides and Special Medical Food Technology Innovation and Development Forum” and the “First Annual Meeting of the Special Medical Food and Bioactive Peptides Working Committee and the Establishment Conference of the Expert Committee” kicked off.

On the 21st, Wen Kai, Secretary General of the Special Medical Food and Bioactive Peptides Working Committee, awarded the annual exemplary organization. Taiai Peptide Group won the title of “2021-2022 exemplary organization”. Zhang Jenny, President of Taiai Peptide Group, as the representative of the annual exemplary organization, made a speech: looking back on the three years of the epidemic, the country has also given great support and help to the big health industry and peptide industry, providing more development space and opportunities for the peptide industry; After 26 years of innovative development, Taiai Peptide Group has been deeply cultivating and innovating in the peptide field, adhering to integrity and innovation, and setting an industry example to provide reliable products for the people; And taking advantage of this conference, we will work together with numerous enterprises to accelerate the development and innovation of China’s active peptide industry in the future, achieve a new situation of co construction, win-win, and sharing, serve the peptide industry well, and strive to build a national owned brand. On the global stage of great health, we will witness the strength of China’s “peptide” brand!

 Subsequently, Mr. Ren Yandong, a medical consultant of Taiai Peptide Group and a dual doctoral degree in Traditional Chinese Medicine and Clinical Nutrition, also gave a wonderful sharing on the theme of “Health Management and International Clinical Nutrition Development Trends – Peptides” at this forum, discussing the relationship between peptides and proteins, amino acids, peptides and clinical nutrition, as well as the clinical practice of peptide clinical deep nutrition.

For the bioactive peptides and specialty food industry, this is an unprecedented international event. Undoubtedly, for over a hundred years, scientists, experts and professors from various countries have devoted themselves to the research of active peptides, with rich scientific research achievements. In the future, Taiai Peptide Group will deepen its research and application in the field of peptides, comprehensively improve and optimize from aspects such as quality, innovation, integrity, culture, talent, marketing, etc., enhance the quality of industrial development, optimize the industrial supply structure, and elevate Taiai Peptide’s development in the peptide field to a higher and more professional level. On the global stage of great health, it will tell the story of Chinese peptide brands well.